Thalassemia Syndromes in Developing Countries: Has Anything Changed?
A special issue of Thalassemia Reports (ISSN 2039-4365).
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 12695
Special Issue Editor
Special Issue Information
Dear Colleagues,
With improving blood transfusion services and provision of adequate chelation in well-supervised settings, the outlook of survival of patients with thalassaemia has significantly improved in Mediterranean countries and other resource-rich settings. Newer medications to raise haemoglobin are being trialled and now gradually used in these centres with some efficacy. But have these positive trends transcended to those cities and countries that have the bulk of thalassaemia patients in the world? Almost half a century after the widespread use of desferrioxamine began, has it reached to the patients who most need it? MRI is the most widely used technique for organ-based iron measurements—how widely used are such tools in the most vulnerable of populations? Has the quality of life in patients with thalassaemia syndromes improved in the developing world?
Dr. Anuja P. Premawardhena
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Thalassemia Reports is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- haemoglobinopathies
- thalassaemia
- survival
- quality of life
- developing world
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.